Dihydrotachysterol/ja - Revision history

Fire: Created page with "{{Sterols/ja}} {{Vitamins/ja}} {{Vitamin D receptor modulators/ja}}"

2024-04-12T13:30:11Z

Created page with "{{Sterols/ja}} {{Vitamins/ja}} {{Vitamin D receptor modulators/ja}}"

← Older revision		Revision as of 22:30, 12 April 2024
Line 48:		Line 48:
	{{Vitamin D receptor modulators/ja}}		{{Vitamin D receptor modulators/ja}}

	~~<div lang="en" dir="ltr" class="mw-content-ltr">~~
	~~{{二次利用\|date=29 January 2023}}~~
	[[Category:Secosteroids]]		[[Category:Secosteroids]]
	[[Category:Vitamin D]]		[[Category:Vitamin D]]
	[[Category:Indanes]]		[[Category:Indanes]]
	[[Category:Conjugated dienes]]		[[Category:Conjugated dienes]]
	~~</div>~~

Fire: Created page with "'''ジヒドロタキステロール'''（DHT）は、肝臓で活性化される合成ビタミンD類似体であり、ビタミンD₂（エルゴカルシフェロール）やビタミンD₃（コレカルシフェロール）のような腎水酸化を必要としない。DHTはビタミンDよりも作用発現が早く（2時間）、半減期が短く、骨..."

2024-04-12T13:30:02Z

Created page with "'''ジヒドロタキステロール'''（DHT）は、肝臓で活性化される合成ビタミンD類似体であり、ビタミンD<sub>2</sub>（エルゴカルシフェロール）やビタミンD<sub>3</sub>（コレカルシフェロール）のような腎水酸化を必要としない。DHTはビタミンDよりも作用発現が早く（2時間）、半減期が短く、骨..."

← Older revision		Revision as of 22:30, 12 April 2024
Line 42:		Line 42:
	}}		}}

	~~<div lang="en" dir="ltr" class="mw-content-ltr">~~		'''ジヒドロタキステロール'''（DHT）は、[[liver /ja\|肝臓]]で活性化される合成[[vitamin D/ja\|ビタミンD]]類似体であり、ビタミンD<sub>2</sub>（[[ergocalciferol/ja\|エルゴカルシフェロール]]）やビタミンD<sub>3</sub>（[[cholecalciferol/ja\|コレカルシフェロール]]）のような[[renal/ja\|腎]]水酸化を必要としない。DHTはビタミンDよりも作用発現が早く（2時間）、半減期が短く、骨塩の[[Mineralization (biology)/ja\|ミネラル化]]に対する作用が大きい。
	'''~~Dihydrotachysterol~~''' ~~(DHT) is a synthetic [[vitamin D]] analog activated in the~~ [[liver]] ~~that does not require~~ [[~~renal~~]] ~~hydroxylation like vitamin D~~<sub>2</sub> ([[ergocalciferol]]~~) and vitamin D~~<sub>3</sub> ([[cholecalciferol]]~~). DHT has a rapid onset of action (2 hours), a shorter half-life, and a greater effect on~~ [[Mineralization (biology)\|~~mineralization~~]] ~~of bone salts than does vitamin D.~~
	~~</div>~~

	~~<div lang="en" dir="ltr" class="mw-content-ltr">~~		{{Sterols/ja}}
	{{Sterols}}		{{Vitamins/ja}}
	{{Vitamins}}		{{Vitamin D receptor modulators/ja}}
	{{Vitamin D receptor modulators}}
	~~</div>~~

	<div lang="en" dir="ltr" class="mw-content-ltr">		<div lang="en" dir="ltr" class="mw-content-ltr">

Fire: Created page with "{{Drugbox | verifiedrevid = 460787840 | IUPAC_name = (1''S'',3''E'',4''S'')-3-[(2''E'')-2-[(1''R'',3a''S'',7a''R'')-1-[(''E'',2''R'',5''R'')-5,6-Dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1''H''-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol | image = Dihydrotachysterol.svg | alt = 構造式 | image2 = Dihydrotachysterol molecule spacefill.png | alt2 = ジヒドロタキステロール分子の空間充填モデル | width = 190 |..."

2024-04-12T13:28:45Z

Created page with "{{Drugbox | verifiedrevid = 460787840 | IUPAC_name = (1''S'',3''E'',4''S'')-3-[(2''E'')-2-[(1''R'',3a''S'',7a''R'')-1-[(''E'',2''R'',5''R'')-5,6-Dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1''H''-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol | image = Dihydrotachysterol.svg | alt = 構造式 | image2 = Dihydrotachysterol molecule spacefill.png | alt2 = ジヒドロタキステロール分子の空間充填モデル | width = 190  |..."

← Older revision		Revision as of 22:28, 12 April 2024
Line 1:		Line 1:
	<languages />		<languages />
	~~<div lang="en" dir="ltr" class="mw-content-ltr">~~
	~~{{Short description\|Chemical compound}}~~
	{{Drugbox		{{Drugbox
	\| verifiedrevid = 460787840		\| verifiedrevid = 460787840
	\| IUPAC_name = (1''S'',3''E'',4''S'')-3-[(2''E'')-2-[(1''R'',3a''S'',7a''R'')-1-[(''E'',2''R'',5''R'')-5,6-Dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1''H''-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol		\| IUPAC_name = (1''S'',3''E'',4''S'')-3-[(2''E'')-2-[(1''R'',3a''S'',7a''R'')-1-[(''E'',2''R'',5''R'')-5,6-Dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1''H''-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol
	\| image = Dihydrotachysterol.svg		\| image = Dihydrotachysterol.svg
	\| alt = ~~Structural formula~~		\| alt = 構造式
	\| image2 = Dihydrotachysterol molecule spacefill.png		\| image2 = Dihydrotachysterol molecule spacefill.png
	\| alt2 = ~~Space-filling model of the dihydrotachysterol molecule~~		\| alt2 = ジヒドロタキステロール分子の空間充填モデル
	\| width = 190		\| width = 190
	<!--Clinical data-->		<!--Clinical data-->
Line 43:		Line 41:
	\| StdInChIKey = ILYCWAKSDCYMBB-OPCMSESCSA-N		\| StdInChIKey = ILYCWAKSDCYMBB-OPCMSESCSA-N
	}}		}}
	~~</div>~~

	<div lang="en" dir="ltr" class="mw-content-ltr">		<div lang="en" dir="ltr" class="mw-content-ltr">

Fire: Created page with "ジヒドロタキステロール"

2024-04-12T13:28:36Z

Created page with "ジヒドロタキステロール"

New page

<languages />
<div lang="en" dir="ltr" class="mw-content-ltr">
{{Short description|Chemical compound}}
{{Drugbox
| verifiedrevid = 460787840
| IUPAC_name = (1''S'',3''E'',4''S'')-3-[(2''E'')-2-[(1''R'',3a''S'',7a''R'')-1-[(''E'',2''R'',5''R'')-5,6-Dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1''H''-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol
| image = Dihydrotachysterol.svg
| alt = Structural formula
| image2 = Dihydrotachysterol molecule spacefill.png
| alt2 = Space-filling model of the dihydrotachysterol molecule
| width = 190

| tradename =
| Drugs.com = {{drugs.com|CONS|dihydrotachysterol}}
| MedlinePlus = a682335
| pregnancy_AU = 
| pregnancy_US = 
| legal_AU = 
| legal_UK = 
| legal_US = 

| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 67-96-9
| ATC_prefix = A11
| ATC_suffix = CC02
| PubChem = 5311071
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01070
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4470607
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = R5LM3H112R
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00299
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 4591

| C=28 | H=46 | O=1
| smiles = O[C@@H]3C/C(=C\C=C1/CCC[C@]2([C@H]1CC[C@@H]2[C@@H](/C=C/[C@H](C)C(C)C)C)C)[C@@H](C)CC3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C28H46O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-22,25-27,29H,7-8,11,14-18H2,1-6H3/b10-9+,23-12+,24-13+/t20-,21-,22+,25-,26+,27-,28+/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ILYCWAKSDCYMBB-OPCMSESCSA-N
}}
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
'''Dihydrotachysterol''' (DHT) is a synthetic [[vitamin D]] analog activated in the [[liver]] that does not require [[renal]] hydroxylation like vitamin D<sub>2</sub> ([[ergocalciferol]]) and vitamin D<sub>3</sub> ([[cholecalciferol]]). DHT has a rapid onset of action (2 hours), a shorter half-life, and a greater effect on [[Mineralization (biology)|mineralization]] of bone salts than does vitamin D.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
{{Sterols}}
{{Vitamins}}
{{Vitamin D receptor modulators}}
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
{{二次利用|date=29 January 2023}}
[[Category:Secosteroids]]
[[Category:Vitamin D]]
[[Category:Indanes]]
[[Category:Conjugated dienes]]
</div>